Susceptibility Factors in Idiosyncratic Drug-Induced Liver Injury Steven Yee Molecular and Cellular Toxicology Section National Institutes of Health

Slides:



Advertisements
Similar presentations
Statins as Protective Agents for Aortic Endothelial Cells Robert Kreisberg West Liberty State College.
Advertisements

Dosimetry in Risk Assessment and a bit More Mel Andersen McKim Conference QSAR and Aquatic Toxicology & Risk Assessment June 27-29, 2006.
Hepatotoxicity of nonsteroidal anti-inflammatory drugs (NSAIDs) in mice Mindi CleggAdvisor: Dr. Brown Hepatotoxicity of nonsteroidal anti-inflammatory.
Arginine: Friend or Foe
Tylenol and Hepatotoxicity Emmanuelle Mirsakov Pharm.D. Candidate 2007 USC School of Pharmacy
Biochemical composition of blood in norm and pathology: acute phase proteins, enzymes of blood plasma.
The Effects of Increased Net Reactive Oxygen Species on Mitophagy DONALD TA.
The Role of Aryl Hydrocarbon Receptor (AhR) in the Immune System of Aging Mice Duy Pham Dr. Nancy I. Kerkvliet Department of Environmental and Molecular.
Pathophysiology of Disease: Chapter 16 ( ) RENAL DISEASE: OVERVIEW AND ACUTE RENAL FAILURE Pathophysiology of Disease: Chapter 16 ( ) Jack.
Acetaminophen is a non-narcotic analgesic, antipyretic, weak anti-inflammatory activity.  COX-3 in CNS   PGs (brain)  COX-3 in CNS   PGs (brain)
University of North Carolina
Acetaminophen and p-Aminophenols
Inflammation and Repair
Asthma & Exercise Physiology and Pathophysiology
Soluble Epoxide Hydrolase Inhibitor Reduces Neuronal Death and NF-kB Activation after Cardiac Arrest Department of Anesthesiology & Perioperative.
Pharmacokinetics: Bioavailability Asmah Nasser, M.D.
Prof JH van Zyl Central role of liver in drug metabolism 02. Principal reactions in drug metabolism 03. Electron flow pathway in the microsomal.
Paracetamol Nimesulide. “ Humanity has but three great enemies; Fever, Famine and War. Of these by far the most terrible, is fever.” ( Sir William Osler.
Danny McAuley Queen’s University of Belfast Scottish Combined Critical Care Conference September 2010 Statins in ARDS.
Mechanisms of Toxicity
Ischemia-Reperfusion injury Su Chang Fu 90/6/19. Ischemia Anesthesiologist: MI, peripheral vascular insufficiency, stroke, and hypovolemic shock Restoration.
Nitric Oxide As a Mediator of Apoptosis Mallika Somayajulu.
Acetaminophen Toxicity. Overview Principle pf the disease Clinical features Diagnosis Management.
Luděk Bláha, PřF MU, RECETOX BIOMARKERS AND TOXICITY MECHANISMS 10 – BIOMARKERS Introduction.
Oxidative Stress, Septic Shock, and Survival Matthew Greenwood April 29, 2015.
Biomarkers Biomarkers - markers in biological systems with a sufficently long half-life which allow location where in the biological system change occur.
1 2 By Hussam A.S. Murad and Khaled A. Mahmoud Department of Pharmacology and Therapeutics Faculty of Medicine, Ain Shams University.
1 Adverse effect of drugs Excessive Pharmacologic Effects –overdoing the therapeutic effect –Atropine –muscarinic antagonist, desired therapeutic –Effect:
Indian Institute of Technology
P ATHOGEN A SSOCIATED M OLECULAR P ATTERNS AND ITS INVOLVEMENT IN THE I NNATE I MMUNE R ESPONSE By: Rebecca D. Riggs.
Wound Healing Dr. Raid Jastania.
Inflammation lecture 4 Dr Heyam Awad FRCPath. Chemical mediators of inflammation VASOACTIVE AMINES AA METABOLITES PAF CYTOKINES REACTIVE OXYGEN SPECIES.
Inflammatory Mediator
Chemical Mediators and Regulators of Inflammation 1 Dr. Hiba Wazeer Al Zou’bi.
Why Georgia Needs Gooder: Health Effects of O3 and PM2.5
Oxidant Mechanisms in Response to Ambient Air Particles Beatriz González-Flecha Department of Environmental Health Harvard School of Public Health Boston,
HYPERLIPIDEMIA  Coronary heart disease (CHD) is the cause of about half of all deaths. The incidence of CHD is correlated with elevated levels of low-density.
Adenosine Protects Vascular Barrier Function in Hyperoxic Lung Injury Jonathan Davies 1, Harry Karmouty-Quintana 2, Thuy T. Le 2, Ning-Yuan Chen 2, Tingting.
Cytochrome P 450 Biochemistry Department. Cytochrome P 450 Unique family of heme proteins present in bacteria, fungi, insects, plants, fish, mammals and.
Lecture # 39 HEMODYNAMICS - 7 Dr. Iram Sohail Assistant Professor Pathology College Of Medicine Majmaah University.
AHMED K. SALAMA AND OMRAN A. OMRAN Medical Laboratories Dept., Faculty of Science, Majmaah University, Kingdom of Saudi Arabia, 1434 H This report is based.
Drug & Toxin-Induced Hepatic Disease
Acetylcysteine for Acetaminophen Poisoning
Dr. Ahmad Hameed MBBS,DCP, M.Phil
* * * * * * * Results Abstract Description of intervention/study
N-acetyl-P-aminophenol
10 – BIOMARKERS Introduction
The average rate at which alcohol is eliminated from the body is ∼7 g/h, which translates to ∼1 drink/h. Alcohol undergoes first pass gastric metabolism.
Andrew E. Williams. , Ricardo J. José, Paul F. Mercer, Jeremy S
In the name of GOD.
Non-narcotic Analgesics
Drug-induced liver injury part II
Toxic responses of the liver
Pathways of liver injury in alcoholic liver disease
Toxicity and the Factors That Modify Toxic Responses
Chemical Mediators Dr Shoaib Raza.
Volume 131, Issue 1, Pages (July 2006)
Non-narcotic Analgesics
Figure 3 The mechanism of injury in ACLF
Figure 3 Cascade of events leading from AKI to ALI
Signalling pathways in alcohol-induced liver inflammation
Benjamin L. Woolbright, Hartmut Jaeschke  Journal of Hepatology 
Volume 18, Issue 3, Pages (June 2011)
Figure 3 Pathological activation of complement
Patrick S. C. Leung, Kit Lam, Mark J. Kurth, Ross L. Coppel, M
Pathways of liver injury in alcoholic liver disease
Inflammatory health effects of indoor and outdoor particulate matter
Volume 146, Issue 4, Pages e1 (April 2014)
Zohair A. Al Aseri MD, FRCPC EM & CCM
Toxic responses of the liver
Presentation transcript:

Susceptibility Factors in Idiosyncratic Drug-Induced Liver Injury Steven Yee Molecular and Cellular Toxicology Section National Institutes of Health 8 June 2004 U.S. Department of Health and Human Services National Institutes of Health National Heart, Lung, and Blood Institute

Occurs in small fraction of individuals Occurs in small fraction of individuals Difficult to predict Difficult to predict Major clinical problem; often life-threatening Major clinical problem; often life-threatening Leading cause of acute liver failure Leading cause of acute liver failure Reason drugs removed from clinical development and widespread use Reason drugs removed from clinical development and widespread use Drug-Induced Liver Injury

Examples of Drugs Withdrawn Due to Liver Disease Iproniazid1956 Ibufenac (in Europe only)1975 Ticrynafen1979 Benoxaprofen1982 Perhexiline (in France)1985 Dilevalol (in Portugal, Ireland)1990 Bromfenac 1998 Troglitazone 2000 Serzone2004

Mechanism often involves drug metabolites Mechanism often involves drug metabolites – Affect critical biochemical functions – Specific immune responses Only a few drugs demonstrate these underlying causes Only a few drugs demonstrate these underlying causes Tissue susceptibility: imbalance between protoxicants and protectants Tissue susceptibility: imbalance between protoxicants and protectants – Environmental factors – Genetic polymorphism Putative Mechanisms

Hepatotoxicants Potentiated by Exposure to Small Doses of Lipopolysaccharide (LPS) Xenobiotics CCl 4 GalactosamineEthanolT2-toxinCadmiumHalothaneLead Allyl Alcohol Aflatoxin B 1 ChlorpromazineRanitidineSource Formal et al., 1960 Galanos et al., 1979 Nolan et al., 1980 Tai and Petska, 1988 Cook et al.., 1974 Lind et al., 1984 Honchel et al., 1991 Sneed et al., 1997 Barton et al., 2000 Buchweitz et al., 2002 Luyendyk et al., 2003

LPS MacrophagesNeutrophils Endothelial Cells Epithelial Cells TLR4 CytokinesCoagulation Factors Platelet Activating FactorComplement Activation LeukotrienesArachidonic Acid Metabolites ProstaglandinsReactive Oxygen Species Nitric Oxide Cellular Level Events of LPS

Monocrotaline (MCT) N CH 2 O O O=C CC=O CC OH CH 3 OH H3CH3CH3CH3C H Monocrotaline Crotalaria Spectabilis (Rattlebox)

N CH 2 O O O=C CC=O CC OH CH 3 OH H3CH3CH3CH3C H MCT N CH 2 O O O=C CC=O CC OH CH 3 OH H3CH3CH3CH3C H MonocrotalinePyrrole(MCTP) CYP 3A Covalent Binding to CellularMacromolecules Cell Death MCT Toxicity

MCT/LPS Treatment Protocol 0 hr 4 hr X hr MCT or Veh(i.p.) LPS or Veh(i.v.) 1. Plasma 2. Liver Male Sprague-Dawley Rats Male Sprague-Dawley Rats

Modest Inflammation Enhances MCT Toxicity LPS 4 hours after MCT

LPS Lowers the Threshold for MCT Toxicity

Kupffer Cell Inactivation Reduces Hepatotoxicity

TNF-  Depletion Attenuates MCT/LPS Hepatotoxicity

Neutrophil Depletion Attenuates MCT/LPS Hepatotoxicity MCT/LPS Hepatotoxicity

Inactivation of the Coagulation System Decreases Liver Injury

Summary

Does a loss in hepatoprotective factors result in drug-induced liver disease? Drug Liver ReactiveMetabolites ProteinAdducts CellularHomeostasisAltered (Inhibition) Response Toxicity Protection IL-6, IL-10, COX-2 Stress Proteins ProtectiveFactors Extensive Liver Injury And Death

Model Compound Many of the protective factors discovered through research on acetaminophen (APAP) toxicity Many of the protective factors discovered through research on acetaminophen (APAP) toxicity Acetaminophen Acetaminophen – Clinically relevant; analgesic, antipyretic – Over 50,000 ER visits per year – 450 death per year Suicide Suicide Accidental ingestion Accidental ingestion “Therapeutic misadventures” “Therapeutic misadventures” – Unlike with drug idiosyncrasy, it is well characterized and reproducible in animals Bioactivation to N-acetyl-p-benzoquinone imine (NAPQI) Bioactivation to N-acetyl-p-benzoquinone imine (NAPQI)

APAP-Induced Liver Injury HNCH 3 O OH ACETAMINOPHEN NCH 3 O O NAPQI SulfationGlucuronidation Detox GSH Detox Cysteinyl Conjugate Protein Adducts Mitochondria Dysfunction Reactive Oxygen Species LIVER INJURY P450 2E1 P450 1A2 P450 3A4 Depleted

Serum Cytokines After Administration of 300 mg APAP/kg to C57BL/6 Mice Bourdi (2002), Hepatology, 35:289

Development of Hepatotoxicity in Mice Given IL-13 Neutralizing Antibody 2 Hours before 200 mg APAP/Kg

Development of Hepatotoxicity in IL-13 KO Mice Treated With 200 mg APAP/Kg

Liver Histopathology at 8 hours CVCV CV CV CV CV CV CV CAb/VehCAb/APAP IL-13 NAb/APAP APAP - KO

Nitric Oxide Pathway L-Arginine L-Ornithine IL-4, IL-10, IL-13 IL-1, IL-6, TNF-  IFN-γ NO iNOS Arginase Citrulline Urea L-NIL Aminoguanidine (AMG) Nitrite/Nitrate Peroxynitrite +Superoxide

Endogenous IL-13 is a hepatoprotective factor in APAP-induced liver injury Endogenous IL-13 is a hepatoprotective factor in APAP-induced liver injury Elevated serum TNF-α concentration – causal role? Elevated serum TNF-α concentration – causal role? Elevated NO levels – causal role? Elevated NO levels – causal role? Deficiency in IL-13 may increase susceptibility to drug-induced liver disease Deficiency in IL-13 may increase susceptibility to drug-induced liver disease Summary

Idiosyncratic Drug-Induced Liver Disease Complex “multihit” process Complex “multihit” process Liver protoxicants and protectants have a role in the overall pathogenesis Liver protoxicants and protectants have a role in the overall pathogenesis – Environmental Factors – Genetic polymorphisms Underproduction of hepatoprotective and overproduction of hepatoprotoxicant factors (i.e., imbalance) influences susceptibility to this liver disease Underproduction of hepatoprotective and overproduction of hepatoprotoxicant factors (i.e., imbalance) influences susceptibility to this liver disease

Determination of Susceptibility Factors Identification of liver protoxicant and protectant factors results in better understanding of mechanism and in facilitating prediction of drug-induced liver disease Identification of liver protoxicant and protectant factors results in better understanding of mechanism and in facilitating prediction of drug-induced liver disease – Inflammatory mediators – COX-2 products – Heat shock proteins Application of new technologies Application of new technologies – Toxicogenomics – Proteomics – Metabonomics

Acknowledgments Michigan State University Robert Roth Patricia Ganey Jack Harkema Chuck Barton John Buchwietz Bryan Copple Shawn Kinser Jim Luyendyk Jane Maddox Rosie Sneed National Institutes of Health Lance Pohl Michael Adams Hamid Amouzadeh Mohammed Bourdi John George Michael Holt Mary Jane Masson Kevin Welch Santana Flores Thomas Wynn, NIAID